Aera Therapeutics utilizes a protein nanoparticle (PNP) delivery platform that self-assembles from endogenous human proteins to package and transfer nucleic acid cargo. This technology addresses the limitations of current delivery methods for genetic medicines, enabling broader therapeutic applications.

Alife provides an AI-powered software platform designed to optimize In Vitro Fertilization (IVF) clinic operations. The platform integrates with EMR systems to deliver actionable insights for embryo grading, patient communication, and lab scheduling. This data-driven approach helps fertility clinics increase efficiency, reduce operating costs, and improve patient satisfaction.

Anduril provides an autonomous operations platform that fuses data from drones, radar, lidar, satellite and other sensors into a real‑time situational awareness picture. Its edge AI and computer‑vision models detect, classify and track objects autonomously, delivering secure analytics to command interfaces for rapid decision‑making. The solution includes modular autonomous vehicles and a scalable command‑and‑control dashboard, enabling defense agencies to deploy advanced surveillance and reconnaissance capabilities with lower lifecycle costs.

Applied Compute builds custom, specialized AI agents by training proprietary models on a company's internal knowledge base. These in-house agent workforces provide deep domain expertise to deliver measurable business value beyond general-purpose models. The company embeds engineers to rapidly develop and deploy these tailored AI solutions directly within client operations.

Applied Intuition provides a unified development platform that enables automotive manufacturers to create, test, and validate advanced driver-assistance systems (ADAS) and automated driving (AD) technologies at scale. This platform reduces development cycles and enhances safety by utilizing simulation and validation tools to identify issues early in the process, ensuring compliance with safety standards.

Benchling provides a cloud-based platform that digitizes laboratory workflows and automates data management for biotechnology research, enabling scientists to efficiently plan, record, and analyze experiments. By reducing time spent on manual data capture and enhancing collaboration, Benchling accelerates the development of biopharmaceuticals and other biotech products.

Bild provides a cloud-native platform for hardware data management, combining Product Data Management (PDM) and Product Lifecycle Management (PLM) capabilities. The system offers version control, change management workflows, and centralized Bill of Materials (BOM) management for complex engineering data. This solution enables hardware teams across industries like aerospace and medical devices to collaborate efficiently and accelerate product development cycles.

Buf provides tools for managing the entire API lifecycle, focusing on integration, monitoring, and version control. This enables companies to minimize operational inefficiencies and accelerate their development cycles, essential for businesses that depend on APIs.

Cajal Therapeutics develops novel small molecule and RNA medicines targeting iron homeostasis for systemic and neurologic diseases. Their therapies aim to restore iron balance, addressing conditions like anemias of inflammation and neurodegenerative disorders. The lead program focuses on an iron mobilizer to restore essential iron transport for cellular processes.

Caper develops AI-powered smart shopping carts equipped with deep learning and computer vision technology to enhance in-store shopping experiences. These carts provide personalized recommendations, streamline checkout processes, and increase customer engagement, resulting in larger basket sizes and improved store operations.

Chronosphere provides an observability platform that enables DevOps teams to manage telemetry data efficiently, reducing costs and improving developer productivity. By offering streamlined troubleshooting and data shaping capabilities, Chronosphere helps organizations quickly identify and resolve infrastructure issues before they impact customer experiences.

Provides a privacy management platform that generates unique virtual identities—such as emails, phone numbers, and passwords—for each online account, reducing the risk of data exposure and identity theft. The service includes tools for encrypted password storage, identity monitoring, data removal from brokers, and $1 million in identity theft insurance, ensuring comprehensive protection against fraud and breaches.

Cognichip develops Artificial Chip Intelligence (ACI®), an AI-first platform for semiconductor design. This technology utilizes a physics-informed foundation AI model to fundamentally alter the economics of chip creation. ACI® provides a new level of intelligence and precision for scaling semiconductor development.

Cognition is an Agent Lab that develops advanced AI software engineers, most notably Devin. This technology automates complex software engineering tasks by providing an end-to-end AI agent capable of planning, execution, and self-correction. The company enables developers and enterprises to scale engineering capacity through autonomous AI assistance.

Column is a software platform that facilitates the publication of legal notices, obituaries, and classifieds by connecting media companies, governments, and legal services. The platform streamlines the notification process, ensuring timely and organized dissemination of important public information.

Autopilot is an AI workspace that generates spreadsheets, documents, presentations, and reports from a single platform. By leveraging reasoning across all user data and agentic capabilities, Autopilot aims to automate complex workflows.

The startup develops visibility tools for industrial automation that enhance quality control, streamline production processes, and improve PLC programming. By providing robust version control and real-time monitoring, these tools enable clients to proactively manage crises and optimize operational efficiency.

Coris AI provides an AI platform for merchant risk management, enabling instant onboarding of good merchants and real-time fraud prevention across card and ACH payments. The platform centralizes merchant intelligence, automates workflows via AI agents, and continuously monitors portfolios to reduce manual reviews and operational overhead. This infrastructure allows businesses to underwrite risk confidently and scale operations efficiently by acting before fraudulent transactions are processed.

Creyon Bio engineers oligonucleotide-based medicines (OBMs) using machine learning models and custom data sets to create precise gene-centric therapies with minimal off-target effects. This approach enables the rapid development of safe and effective treatments for both rare and common diseases, significantly reducing costs and time to market.

Databricks provides a unified Data Intelligence Platform that combines data lake and warehouse capabilities into a single, scalable environment for data storage, governance, ETL, analytics, and AI model development. The platform offers serverless PostgreSQL lakebases, integrated open‑source tools like Spark, Delta Lake, and MLflow, and multi‑cloud support to reduce operational complexity and total cost of ownership for enterprise data and AI teams.

DeepSpin is developing an AI-powered MRI imaging system that is portable, affordable, and user-friendly, reducing the cost of MRI machines by 20 times while maintaining high image quality. This technology addresses the accessibility issue of MRI, making it available to a broader population, including those in developing countries.

The startup develops a gene editing and genome engineering platform that creates human-compatible organ tissue cells for solid organ and therapeutic cell transplantation. This technology aims to improve outcomes for patients with life-threatening diseases by enabling successful kidney and islet cell transplants.

Eikon Therapeutics offers a platform that combines high‑throughput single‑molecule imaging with deep‑learning analytics to produce quantitative molecular maps of cancer and neuro‑degenerative pathways. The system prioritizes therapeutic targets, predicts efficacy, and supports biomarker generation for immune‑modulation and synthetic‑lethality programs, delivering data packages ready for IND‑enabling studies. The platform is licensed to pharmaceutical, biotech, and academic partners for target discovery and preclinical development.

EvolutionaryScale develops biological artificial intelligence models, specifically ESM3, to generate and design proteins by analyzing sequence, structure, and function data. This technology enables scientists to create novel proteins, such as esmGFP, significantly faster than natural evolutionary processes, enhancing therapeutic design capabilities in life sciences.